Through Venomics Project, a team of European researchers has analysed the venoms of 203 different animal species, from which it has selected 5,700 sequences of innovative pharmaceutical interest. Over the next few weeks, the research centre CEA Saclay and the company Zealand Pharma will start a search for peptides of pharmacological potential for pain, diabetes, cancer and autoimmune diseases. Venomics Project, financed by European funds and carried out by leading companies and research centres from Belgium, Denmark, France, Portugal and Spain, will finish with this work line.
In Copenhagen, the project's members will discuss the latest results and plan the final stages of the project. During the meeting, on June the 10th, they will participate in a press event to update on the latest advances of the project and answer questions.
Press contact: email@example.com